3Nagata S,Golstein P.The Fas death factor [J].Science,1995,267:1449 - 1456.
4Bennett MW,O' Connel J,O' Sullivan GC,et al.The Fas counterattack in vivo apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas Ligand expression by human esophageal carcinoma[J].J Immunol,1998,160:5669 - 5673.
5Shiraki K,Tsuji N,Shiode T,et al.Expression of Fas Ligand in liver metastases of human colonic adenocarcinoma [J].Proc Natl Acad Sci USA,1997,94:6420-6425.
6O' Connel J,Bennett MW,O' Sullivan GC,et al.Expression of Fas ( CD95/APO21 ) ligand by human gastric adenocarcinomas:a potential mechanismof immune escape in stomach cancer [J].Gut,1999,44:156 - 162.
7Nagata S,Golstein P. The Fas death factor. Science,1995,267:1449-1456.
8Bennett MW,O'Connel J,O'Sullivan GC,et al.The Fas counterattack in vivo apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas Ligand expression by human esophageal carcinoma.J Immunol,1998,160:5669-5673.
9Shiraki K,Tsuji N,Shiode T,et al.Expression of Fas Ligand in liver metastases of human colonic adenocarcinoma.Proc Natl Acad Sci USA,1997,94:6420-6425.
10O'Connel J,Bennett MW,O'Sullivan GC, et al. Expression of Fas(CD95/APO-1) ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.Gut,1999,44:156-162.
